NCT04712266View on ClinicalTrials.gov

A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

January 10, 2021

Conditions
Type 1 Diabetes Mellitus With Hypoglycemia
Interventions
DRUG

Glucagon

calculated IV insulin:Glucagon molar ratio

DRUG

Insulin

calculated IV Insulin dose infused at a constant rate

Trial Locations (1)

30318

Atlanta Diabetes Associates, Atlanta

Sponsors
All Listed Sponsors
collaborator

T1D Exchange, United States

OTHER

lead

Abvance Therapeutics

INDUSTRY

NCT04712266 - A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter